Homologous Recombination Abnormalities Associated With Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data
Background: Homologous recombination deficiency (HRD) is the hallmark of breast cancer gene 1/2 ( BRCA1/2 )-mutated tumors and the unique biomarker for predicting response to double-strand break (DSB)–inducing drugs. The demonstration of HRD in tumors with mutations in genes other than BRCA1/2 is co...
Main Authors: | Maher Albitar, Hong Zhang, Andrew Pecora, Stanley Waintraub, Deena Graham, Mira Hellmann, Donna McNamara, Ahmad Charifa, Ivan De Dios, Wanlong Ma, Andre Goy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-09-01
|
Series: | Breast Cancer: Basic and Clinical Research |
Online Access: | https://doi.org/10.1177/11782234231198979 |
Similar Items
-
Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors
by: Maher Albitar, et al.
Published: (2023-05-01) -
Investigating the role of homologous recombination in the maintenance of chromosome stability
by: Graham, E
Published: (2023) -
Next-generation sequencing-based analysis of homologous recombination repair gene variant in ovarian cancer
by: Yaolin Song, et al.
Published: (2024-01-01) -
The Regulation of Homologous Recombination by Helicases
by: Eric Huselid, et al.
Published: (2020-05-01) -
Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next‐generation sequencing
by: Huiqin Jiang, et al.
Published: (2023-07-01)